Cargando…

Osteoglycin – A switch from angiogenesis to T-cell recruitment?

Detalles Bibliográficos
Autor principal:	Dimberg, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161477/ https://www.ncbi.nlm.nih.gov/pubmed/30126821 http://dx.doi.org/10.1016/j.ebiom.2018.08.020

Ejemplares similares

The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis
por: Kampmann, Andreas, et al.
Publicado: (2008)

Osteoglycin: An ECM Factor Regulating Fibrosis and Tumorigenesis
por: Nulali, Jiayida, et al.
Publicado: (2022)

Osteoglycin, a novel coordinator of bone and glucose homeostasis
por: Lee, N.J., et al.
Publicado: (2018)

C/EBPβ LIP augments cell death by inducing osteoglycin
por: Wassermann-Dozorets, Rina, et al.
Publicado: (2017)

Low Levels of Plasma Osteoglycin in Patients with Complex Coronary Lesions
por: Seki, Toshiki, et al.
Publicado: (2018)

Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs
por: Chen, Xia, et al.
Publicado: (2017)

Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer
por: Hu, Xiang, et al.
Publicado: (2018)

Osteoglycin inhibition by microRNA miR-155 impairs myogenesis
por: Freire, Paula Paccielli, et al.
Publicado: (2017)

Associations of Circulating Osteoglycin With Bone Parameters and Metabolic Markers in Patients With Diabetes
por: Starup-Linde, Jakob Kau, et al.
Publicado: (2021)

Vertebrate SLRP family evolution and the subfunctionalization of osteoglycin gene duplicates in teleost fish
por: Costa, R. A., et al.
Publicado: (2018)

Serum levels of iCAF‐derived osteoglycin predict favorable outcome in pancreatic cancer
por: Dings, Mark P. G., et al.
Publicado: (2022)

Osteoglycin as a Potential Biomarker of Mild Kidney Function Impairment in Type 2 Diabetes Patients
por: González-Salvatierra, Sheila, et al.
Publicado: (2021)

Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling
por: Mei, Yu, et al.
Publicado: (2017)

Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway
por: Hu, Xiang, et al.
Publicado: (2018)

Tumor angiogenesis: causes, consequences, challenges and opportunities
por: Lugano, Roberta, et al.
Publicado: (2019)

Chrysophanol inhibits the osteoglycin/mTOR and activats NF2 signaling pathways to reduce viability and proliferation of malignant meningioma cells
por: Wang, Jiapeng, et al.
Publicado: (2021)

Commentary: What switch, to switch or not to switch: That is the question!
por: Kavarana, Minoo N.
Publicado: (2020)

The Effects of Acute High‐Intensity Interval Exercise and Hyperinsulinemic‐Euglycemic Clamp on Osteoglycin Levels in Young and Middle‐Aged Men
por: Bauer, Carlie, et al.
Publicado: (2022)

Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway
por: Xu, Tao, et al.
Publicado: (2019)

From opto- to radio-genetics: A switch in the wavelength
por: Proft, Juliane, et al.
Publicado: (2012)

A novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis
por: Rienks, Marieke, et al.
Publicado: (2016)

Recruitment and retention of lung volume
por: Lapinsky, Stephen E
Publicado: (2003)

Recruited monocytes repair infections
por: Kratofil, Rachel M., et al.
Publicado: (2022)

Emerging Role of VEGFC in Pathological Angiogenesis
por: Nagai, Nao, et al.
Publicado: (2015)

Considerations for Program Directors in the 2020–2021 Remote Resident Recruitment
por: Soeprono, Thomas M., et al.
Publicado: (2020)

Humanities and Geriatric Education: a Strategy for Recruitment?
por: Frank, Christopher, et al.
Publicado: (2015)

PGC-1α: The Missing Ingredient for Mesenchymal Stem Cell–Mediated Angiogenesis
por: Hsueh, Willa A., et al.
Publicado: (2012)

How best to recruit the injured lung?
por: Marini, John J
Publicado: (2008)

New Mechanisms and Pathways for Monocyte Recruitment
por: Muller, William A.
Publicado: (2001)

PRMT7: a survive-or-die switch in cancer stem cells
por: Nicot, Christophe
Publicado: (2022)

Dynamic regulation of tumour progression by phenotype‐switching drivers
por: Vock, Laurenz, et al.
Publicado: (2022)

Interaction of Adipogenesis and Angiogenesis in Dietary-Induced Obesity
por: Jia, Guanghong, et al.
Publicado: (2015)

Switching the rate and pattern of cell division for neural tube closure
por: Ogura, Yosuke, et al.
Publicado: (2016)

Commentary on strategies for switching antipsychotics
por: Davis, John M, et al.
Publicado: (2008)

FAM3A – A mitochondrial route to the stimulation of angiogenesis?
por: Davidson, Sean M.
Publicado: (2019)

Do recruitment maneuvers simply improve oxygenation?
por: Valenza, Franco
Publicado: (2010)

Botulinum Toxin in Pediatric Neurology: Switching Lanes From Death to Life
por: Moawad, Eman M. I., et al.
Publicado: (2015)

Respiratory infections and pneumonia: potential benefits of switching from smoking to vaping
por: Campagna, Davide, et al.
Publicado: (2016)

Switching to Tenecteplase from Alteplase for Ischemic Stroke: Is it the Time for Universal Adoption?
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Dendritic and Natural Killer Cells Cooperate in the Control/Switch of Innate Immunity
por: Zitvogel, Laurence
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_msblq080s72v2en83rj7iefrkf